$AMS
AMERICAN SHARED HOSPITAL SERVICES Stock $ams

$ams Overview Financials Valuation SEC Filings Company Website

2015 Q1 Form 10-Q Financial Statement

#000114420415030707 Filed on May 14, 2015

Income Statement

Concept	2015 Q1	2014 Q4	2014 Q1
Revenue	$4.117M	$3.990M	$4.064M
YoY Change	1.3%	1.27%	-12.94%
Cost Of Revenue	$2.520M	$2.450M	$2.775M
YoY Change	-9.19%	-5.41%	8.82%
Gross Profit	$1.597M	$1.540M	$1.289M
YoY Change	23.89%	14.07%	-39.14%
Gross Profit Margin	38.79%	38.6%	31.72%
Selling, General & Admin	$821.0K	$840.0K	$922.0K
YoY Change	-10.95%	12.0%	-25.34%
% of Gross Profit	51.41%	54.55%	71.53%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.517M	$1.570M	$1.679M
YoY Change	-9.65%	-5.42%	13.06%
% of Gross Profit	94.99%	101.95%	130.26%
Operating Expenses	$821.0K	$840.0K	$922.0K
YoY Change	-10.95%	12.0%	-25.34%
Operating Profit	$456.0K	$700.0K	-$103.0K
YoY Change	-542.72%	16.67%	-125.0%
Interest Expense	$320.0K	-$310.0K	$470.0K
YoY Change	-31.91%	-53.73%	-0.21%
% of Operating Profit	70.18%	-44.29%
Other Income/Expense, Net
YoY Change
Pretax Income	$462.0K	$390.0K	-$79.00K
YoY Change	-684.81%	-657.14%	-127.72%
Income Tax	$130.0K	$100.0K	-$30.00K
% Of Pretax Income	28.14%	25.64%
Net Earnings	$128.0K	$60.00K	-$96.00K
YoY Change	-233.33%	-175.0%	-484.0%
Net Earnings / Revenue	3.11%	1.5%	-2.36%
Basic Earnings Per Share	$0.02		-$0.02
Diluted Earnings Per Share	$0.02	$10.83K	-$0.02
COMMON SHARES
Basic Shares Outstanding	5.477M shares	5.361M shares	4.608M shares
Diluted Shares Outstanding	5.526M shares

Balance Sheet

Concept	2015 Q1	2014 Q4	2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$930.0K	$10.06M	$960.0K
YoY Change	-3.13%	426.7%	-90.68%
Cash & Equivalents	$927.0K	$1.059M	$957.0K
Short-Term Investments	$0.00	$9.000M
Other Short-Term Assets	$870.0K	$870.0K	$1.170M
YoY Change	-25.64%	-23.01%	1.74%
Inventory
Prepaid Expenses
Receivables	$3.867M	$3.192M	$4.889M
Other Receivables	$191.0K	$131.0K	$240.0K
Total Short-Term Assets	$5.853M	$14.25M	$7.255M
YoY Change	-19.32%	84.88%	-55.41%
LONG-TERM ASSETS
Property, Plant & Equipment	$49.87M	$50.04M	$49.92M
YoY Change	-0.1%	-2.62%	-4.4%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$2.709M	$2.709M	$11.70M
YoY Change	-76.85%	-76.85%	334.94%
Other Assets	$517.0K	$536.0K	$910.0K
YoY Change	-43.19%	-43.82%	-7.14%
Total Long-Term Assets	$53.10M	$53.28M	$62.53M
YoY Change	-15.07%	-16.8%	11.89%
TOTAL ASSETS
Total Short-Term Assets	$5.853M	$14.25M	$7.255M
Total Long-Term Assets	$53.10M	$53.28M	$62.53M
Total Assets	$58.95M	$67.53M	$69.78M
YoY Change	-15.52%	-5.87%	-3.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$301.0K	$421.0K	$900.0K
YoY Change	-66.56%	-26.4%	109.3%
Accrued Expenses	$1.240M	$940.0K	$1.680M
YoY Change	-26.19%	-45.66%	23.53%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$8.780M	$0.00
YoY Change
Long-Term Debt Due	$2.016M	$2.005M	$8.560M
YoY Change	-76.45%	-58.26%	8.49%
Total Short-Term Liabilities	$7.583M	$16.25M	$11.83M
YoY Change	-35.9%	37.9%	13.42%
LONG-TERM LIABILITIES
Long-Term Debt	$20.61M	$20.78M	$30.77M
YoY Change	-33.02%	-36.12%	-8.42%
Other Long-Term Liabilities	$860.0K	$870.0K
YoY Change
Total Long-Term Liabilities	$21.47M	$21.65M	$30.77M
YoY Change	-30.22%	-33.45%	-8.42%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.583M	$16.25M	$11.83M
Total Long-Term Liabilities	$21.47M	$21.65M	$30.77M
Total Liabilities	$10.20M	$19.37M	$42.69M
YoY Change	-76.1%	-20.56%	-18.16%
SHAREHOLDERS EQUITY
Retained Earnings	$5.670M	$5.542M	$6.398M
YoY Change	-11.38%	-14.66%
Common Stock	$15.92M	$15.88M	$5.016M
YoY Change	217.38%	17.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$21.59M	$21.43M	$19.55M
YoY Change
Total Liabilities & Shareholders Equity	$58.95M	$67.53M	$69.78M
YoY Change	-15.52%	-5.87%	-3.28%

Cashflow Statement

Concept	2015 Q1	2014 Q4	2014 Q1
OPERATING ACTIVITIES
Net Income	$128.0K	$60.00K	-$96.00K
YoY Change	-233.33%	-175.0%	-484.0%
Depreciation, Depletion And Amortization	$1.517M	$1.570M	$1.679M
YoY Change	-9.65%	-5.42%	13.06%
Cash From Operating Activities	$1.330M	$2.360M	$1.400M
YoY Change	-5.0%	31.84%	-25.53%
INVESTING ACTIVITIES
Capital Expenditures	$188.0K	-$4.870M	$147.0K
YoY Change	27.89%	-408.23%	23.53%
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change
Cash From Investing Activities	-$190.0K	-$4.880M	-$150.0K
YoY Change	26.67%	-406.92%	25.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00		$2.000K
YoY Change	-100.0%		-99.31%
Debt Paid & Issued, Net	$401.0K		$956.0K
YoY Change	-58.05%		21.01%
Cash From Financing Activities	-1.270M	2.170M	-2.190M
YoY Change	-42.01%	-162.36%	8.42%
NET CHANGE
Cash From Operating Activities	1.330M	2.360M	1.400M
Cash From Investing Activities	-190.0K	-4.880M	-150.0K
Cash From Financing Activities	-1.270M	2.170M	-2.190M
Net Change In Cash	-130.0K	-350.0K	-940.0K
YoY Change	-86.17%	250.0%	261.54%
FREE CASH FLOW
Cash From Operating Activities	$1.330M	$2.360M	$1.400M
Capital Expenditures	$188.0K	-$4.870M	$147.0K
Free Cash Flow	$1.142M	$7.230M	$1.253M
YoY Change	-8.86%	3342.86%	-28.85%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1059000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	927000	USD
CY2015Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	50000	USD
CY2014Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	50000	USD
CY2014Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	763000	USD
CY2015Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	26434000	USD
CY2014Q1	us-gaap	Foreign Currency Transaction Gain Before Tax ForeignCurrencyTransactionGainBeforeTax	15000	USD
CY2015Q1	us-gaap	Deposits Assets Current DepositsAssetsCurrent	0	USD
CY2014Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	9000000	USD
CY2015Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3867000	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3192000	USD
CY2015Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	191000	USD
CY2014Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	131000	USD
CY2015Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	451000	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	448000	USD
CY2015Q1	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	367000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	367000	USD
CY2014Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	12190000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	3473000	USD
CY2015Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	5670000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	5542000	USD
CY2015Q1	us-gaap	Stockholders Equity StockholdersEquity	21590000	USD
CY2015Q1	us-gaap	Assets Current AssetsCurrent	5853000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	14247000	USD
CY2015Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	85431000	USD
CY2014Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	82151000	USD
CY2015Q1	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	721000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	721000	USD
CY2015Q1	ams	Deposits And Construction In Progress Gross DepositsAndConstructionInProgressGross	11433000	USD
CY2014Q4	ams	Deposits And Construction In Progress Gross DepositsAndConstructionInProgressGross	13736000	USD
CY2015Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	97585000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	96608000	USD
CY2015Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	47711000	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	46572000	USD
CY2015Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	49874000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	50036000	USD
CY2015Q1	us-gaap	Equity Method Investments EquityMethodInvestments	2709000	USD
CY2014Q4	us-gaap	Equity Method Investments EquityMethodInvestments	2709000	USD
CY2015Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	517000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	536000	USD
CY2015Q1	us-gaap	Assets Assets	58953000	USD
CY2014Q4	us-gaap	Assets Assets	67528000	USD
CY2015Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	301000	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	421000	USD
CY2015Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	111000	USD
CY2014Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	179000	USD
CY2015Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1126000	USD
CY2015Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	2016000	USD
CY2014Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2005000	USD
CY2015Q1	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	4029000	USD
CY2014Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	4103000	USD
CY2015Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	USD
CY2014Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	8780000	USD
CY2015Q1	us-gaap	Liabilities Current LiabilitiesCurrent	7583000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	16251000	USD
CY2015Q1	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	8186000	USD
CY2014Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	8586000	USD
CY2015Q1	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	12420000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	21426000	USD
CY2015Q1	us-gaap	Minority Interest MinorityInterest	4844000	USD
CY2014Q4	us-gaap	Minority Interest MinorityInterest	4728000	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	26154000	USD
CY2015Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	58953000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	67528000	USD
CY2014Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4608000	shares
CY2015Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5477000	shares
CY2014Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	26000	USD
CY2015Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	36000	USD
CY2015Q1	ams	Investment Percentage In Common Stock InvestmentPercentageInCommonStock	0.0077	pure
CY2015Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-2400000	USD
CY2014	us-gaap	Line Of Credit Facility Maximum Amount Outstanding During Period LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod	9000000	USD
CY2015Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	3473000	USD
CY2015Q1	us-gaap	Common Stock Value CommonStockValue	10376000	USD
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	10376000	USD
CY2015Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	5544000	USD
CY2014Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	5508000	USD
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5361000	shares
CY2015Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5361000	shares
CY2014Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1611000	USD
CY2015Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1505000	USD
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5361000	shares
CY2014Q1	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	4064000	USD
CY2015Q1	us-gaap	Debt Instrument Interest Rate Terms DebtInstrumentInterestRateTerms	the banks prime rate minus 0.5 percentage point, or alternatively at the Companys discretion, the LIBOR rate plus 1.0 percentage point
CY2015Q1	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0140	pure
CY2015Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	977000	USD
CY2014Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1109000	USD
CY2014Q4	us-gaap	Certificates Of Deposit At Carrying Value CertificatesOfDepositAtCarryingValue	9000000	USD
CY2015Q1	us-gaap	Cost Method Investments CostMethodInvestments	2709000	USD
CY2014Q4	us-gaap	Cost Method Investments CostMethodInvestments	2709000	USD
CY2015Q1	ams	Assets Carrying Value AssetsCarryingValue	3686000	USD
CY2014Q4	ams	Assets Carrying Value AssetsCarryingValue	12818000	USD
CY2014Q4	us-gaap	Line Of Credit LineOfCredit	8780000	USD
CY2015Q1	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	10202000	USD
CY2014Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	10591000	USD
CY2015Q1	us-gaap	Liabilities Liabilities	10202000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	19371000	USD
CY2015Q1	ams	Restricted Cash And Cash Equivalents Fair Value RestrictedCashAndCashEquivalentsFairValue	977000	USD
CY2014Q4	ams	Restricted Cash And Cash Equivalents Fair Value RestrictedCashAndCashEquivalentsFairValue	1109000	USD
CY2014Q4	ams	Certificates Of Deposit At Fair Value CertificatesOfDepositAtFairValue	9000000	USD
CY2015Q1	us-gaap	Cost Method Investments Fair Value Disclosure CostMethodInvestmentsFairValueDisclosure	330000	USD
CY2014Q4	us-gaap	Cost Method Investments Fair Value Disclosure CostMethodInvestmentsFairValueDisclosure	330000	USD
CY2015Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	1307000	USD
CY2014Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	10439000	USD
CY2014Q4	us-gaap	Lines Of Credit Fair Value Disclosure LinesOfCreditFairValueDisclosure	8780000	USD
CY2015Q1	us-gaap	Fair Value Liabilities Measured On Recurring Basis Obligations FairValueLiabilitiesMeasuredOnRecurringBasisObligations	10421000	USD
CY2014Q4	us-gaap	Fair Value Liabilities Measured On Recurring Basis Obligations FairValueLiabilitiesMeasuredOnRecurringBasisObligations	10658000	USD
CY2015Q1	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	10421000	USD
CY2014Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	19438000	USD
CY2008Q4	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	1000000	shares
CY2015Q1	us-gaap	Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased	72000	shares
CY2014Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	100000	USD
CY2015Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	100000	USD
CY2015Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5361000	shares
CY2015Q1	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	4117000	USD
CY2014Q1	us-gaap	Direct Operating Maintenance Supplies Costs DirectOperatingMaintenanceSuppliesCosts	487000	USD
CY2015Q1	us-gaap	Direct Operating Maintenance Supplies Costs DirectOperatingMaintenanceSuppliesCosts	333000	USD
CY2014Q1	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	677000	USD
CY2015Q1	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	682000	USD
CY2014Q1	us-gaap	Cost Of Revenue CostOfRevenue	2775000	USD
CY2015Q1	us-gaap	Cost Of Revenue CostOfRevenue	2520000	USD
CY2014Q1	us-gaap	Gross Profit GrossProfit	1289000	USD
CY2015Q1	us-gaap	Gross Profit GrossProfit	1597000	USD
CY2014Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	922000	USD
CY2015Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	821000	USD
CY2014Q1	us-gaap	Interest Expense InterestExpense	470000	USD
CY2015Q1	us-gaap	Interest Expense InterestExpense	320000	USD
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-103000	USD
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	456000	USD
CY2014Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	15000	USD
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2015Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	6000	USD
CY2015Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	0	USD
CY2014Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	9000	USD
CY2015Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1517000	USD
CY2014Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-52000	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-79000	USD
CY2015Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	462000	USD
CY2014Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-30000	USD
CY2015Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	130000	USD
CY2014Q1	us-gaap	Profit Loss ProfitLoss	-49000	USD
CY2015Q1	us-gaap	Profit Loss ProfitLoss	332000	USD
CY2014Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	47000	USD
CY2015Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	204000	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	-96000	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	128000	USD
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2014Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	0	USD
CY2014Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-95000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	128000	USD
CY2014Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	USD
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	USD
CY2014Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-95000	USD
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	128000	USD
CY2012Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24830000	USD
CY2014	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2000	USD
CY2014	ams	Private Placement Common Stock PrivatePlacementCommonStock	1800000	USD
CY2013	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	88000	USD
CY2014	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	373000	USD
CY2015Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	36000	USD
CY2013	ams	Investment In Subsidiaries By Noncontrolling Interests InvestmentInSubsidiariesByNoncontrollingInterests	184000	USD
CY2014	ams	Investment In Subsidiaries By Noncontrolling Interests InvestmentInSubsidiariesByNoncontrollingInterests	517000	USD
CY2013	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-142000	USD
CY2014	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	779000	USD
CY2013	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	792000	USD
CY2014	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	951000	USD
CY2015Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	88000	USD
CY2013	us-gaap	Profit Loss ProfitLoss	-113000	USD
CY2014	us-gaap	Profit Loss ProfitLoss	-562000	USD
CY2013Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24055000	USD
CY2014Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1679000	USD
CY2015Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2015Q1	us-gaap	Share Based Compensation ShareBasedCompensation	36000	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	735000	USD
CY2014Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	0	USD
CY2015Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-9000	USD
CY2014Q1	us-gaap	Increase Decrease In Deferred Revenue And Customer Advances And Deposits IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits	-12000	USD
CY2015Q1	us-gaap	Increase Decrease In Deferred Revenue And Customer Advances And Deposits IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits	17000	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	283000	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	141000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	1404000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	1329000	USD
CY2014Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	147000	USD
CY2015Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	188000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-147000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-188000	USD
CY2014Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	956000	USD
CY2015Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	401000	USD
CY2014Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	1079000	USD
CY2015Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	1004000	USD
CY2014Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	60000	USD
CY2015Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
CY2014Q1	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	0	USD
CY2015Q1	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	8780000	USD
CY2014Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	59000	USD
CY2015Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	USD
CY2014Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	274000	USD
CY2015Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	88000	USD
CY2014Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2000	USD
CY2015Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-2192000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-1273000	USD
CY2014Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-17000	USD
CY2015Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	0	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-952000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-132000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1909000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	957000	USD
CY2014Q1	us-gaap	Interest Paid InterestPaid	541000	USD
CY2015Q1	us-gaap	Interest Paid InterestPaid	438000	USD
CY2014Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	21000	USD
CY2015Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	-5000	USD
CY2014Q1	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	0	USD
CY2015Q1	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	1160000	USD
CY2014Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	15000	USD
CY2015Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	0	USD
CY2015Q1	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2014-12-31
CY2015Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	857000	USD
CY2014Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	874000	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	145000	USD
CY2014Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	0	USD
CY2015Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-12000	USD
CY2014Q1	us-gaap	Payments For Proceeds From Deposit On Loan PaymentsForProceedsFromDepositOnLoan	0	USD
CY2015Q1	us-gaap	Payments For Proceeds From Deposit On Loan PaymentsForProceedsFromDepositOnLoan	-9000000	USD
CY2015Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5526000	shares
CY2015Q1	dei	Document Type DocumentType	10-Q
CY2015Q1	dei	Amendment Flag AmendmentFlag	false
CY2015Q1	dei	Document Period End Date DocumentPeriodEndDate	2015-03-31
CY2015Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
CY2015Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2015Q1	dei	Entity Registrant Name EntityRegistrantName	AMERICAN SHARED HOSPITAL SERVICES
CY2015Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000744825
CY2015Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2015Q1	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2015Q1	dei	Trading Symbol TradingSymbol	AMS
CY2015Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5361000	shares
CY2015Q1	ams	Non Refundable Deposits NonRefundableDeposits	5000000	USD

Files In Submission

Name	View Source	Status
0001144204-15-030707-index-headers.html	Edgar Link	pending
0001144204-15-030707-index.html	Edgar Link	pending
0001144204-15-030707.txt	Edgar Link	pending
0001144204-15-030707-xbrl.zip	Edgar Link	pending
ams-20150331.xml	Edgar Link	completed
ams-20150331.xsd	Edgar Link	pending
ams-20150331_cal.xml	Edgar Link	unprocessable
ams-20150331_def.xml	Edgar Link	unprocessable
ams-20150331_lab.xml	Edgar Link	unprocessable
ams-20150331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v408854_10q.htm	Edgar Link	pending
v408854_ex31-1.htm	Edgar Link	pending
v408854_ex31-2.htm	Edgar Link	pending
v408854_ex32-1.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AMS
AMERICAN SHARED HOSPITAL SERVICES Stock $ams

2015 Q1 Form 10-Q Financial Statement

#000114420415030707 Filed on May 14, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMS AMERICAN SHARED HOSPITAL SERVICES Stock $ams

2015 Q1 Form 10-Q Financial Statement

#000114420415030707 Filed on May 14, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMS
AMERICAN SHARED HOSPITAL SERVICES Stock $ams